EverGlade Insights Archives - Page 5 of 9 - EverGlade

EverGlade Insights

US_UK Technology Prosperity Deal

The U.S.–U.K. Technology Prosperity Deal: A Strategic Framework for Shared Innovation

Leave a Comment / All Posts, Emerging Technologies / By

On September 18, 2025, the Governments of the United States and the United Kingdom signed a Memorandum of Understanding Between the Government of the United States of America and the Government of the United Kingdom of Great Britain and Northern Ireland Regarding the Technology Prosperity Deal. This MOU reflects both countries’ commitment to partnering on […]

The U.S.–U.K. Technology Prosperity Deal: A Strategic Framework for Shared Innovation Read More »

DARPA’s MASH Program: Autonomous Trauma Care for the Battlefield

1 Comment / DARPA, Emerging Technologies / By

DARPA-PS-25-34 (2) Medics Autonomously Stopping Hemorrhage (MASH) The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has announced the Medics Autonomously Stopping Hemorrhage (MASH) program (DARPA-PS-25-34). This initiative targets one of the leading causes of preventable battlefield deaths: non-compressible torso hemorrhage (NCTH). With nearly a quarter of combat fatalities in recent

DARPA’s MASH Program: Autonomous Trauma Care for the Battlefield Read More »

Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors

Leave a Comment / JPEO, Life Sciences / By

The Medical CBRN Defense Consortium (MCDC), in collaboration with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Information (RFI) to assess industry capabilities in developing broad spectrum prophylactic medical countermeasures (MCMs) against acetylcholinesterase (AChE) inhibitors. These inhibitors, chemical agents that can severely impair nervous system

Broad Spectrum Prophylactics for Acetylcholinesterase Inhibitors Read More »

BARDA Issues New RPP to Advance Smart Manufacturing for Antibodies

Leave a Comment / BARDA, Life Sciences / By

Driving Innovation in Antibody Manufacturing The Biomedical Advanced Research and Development Authority (BARDA) has launched a new Request for Project Proposals (RPP) aimed at transforming the speed, efficiency, and resilience of antibody (Ab) production. Issued under the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), the initiative seeks to integrate advanced manufacturing technologies into Ab production systems to

BARDA Issues New RPP to Advance Smart Manufacturing for Antibodies Read More »

DTRA–MTEC Pre-Announcement for Biodefense Readiness RPP

Leave a Comment / DTRA, Life Sciences / By

MTEC-25-DTRA Pre-Announcement: Advancing Biodefense Readiness The Medical Technology Enterprise Consortium (MTEC), in support of the Defense Threat Reduction Agency (DTRA), has issued a pre-announcement for an upcoming Request for Project Proposals (RPP). This RPP will be aimed at accelerating medical countermeasures (MCMs) and fieldable biosurveillance technologies across the Chemical and Biological Defense Program. In brief,

DTRA–MTEC Pre-Announcement for Biodefense Readiness RPP Read More »

ASPR RFI on Essential Medicines Industrial Base

Leave a Comment / ASPR-IBx, Life Sciences / By

ASPR Industrial Base Management and Supply Chain Request for Information (RFI) Strengthening the U.S. Pharmaceutical Supply Chain: ASPR’s Essential Medicines RFI The U.S. Department of Health and Human Services (HHS), through its Administration for Strategic Preparedness and Response (ASPR), recently issued a Request for Information (RFI) to industry partners regarding domestic manufacturing capabilities for essential

ASPR RFI on Essential Medicines Industrial Base Read More »

NIH Guidance on International Subcontracting

Leave a Comment / Life Sciences, NIH / By

Maximizing the Value of Foreign Collaborations While Safeguarding U.S. Investments The National Institutes of Health (NIH), the nation’s primary medical research agency, recently issued guidance on the use of international subcontractors in NIH-funded research. This announcement reflects NIH’s dual mission: advancing health outcomes for Americans while ensuring responsible stewardship of U.S. taxpayer dollars. While global

NIH Guidance on International Subcontracting Read More »

The NIH’s Strategic Plan for Autoimmune Disease Research

Leave a Comment / Life Sciences, NIH / By

Enhancing Innovation, Collaboration, and Impact Autoimmune diseases are one of the most significant and complex public health challenges of our time. Affecting an estimated 23.5 to 50 million Americans, these conditions range from rheumatoid arthritis and type 1 diabetes to multiple sclerosis and lupus, impacting nearly every organ system and disproportionately affecting women (over 80%

The NIH’s Strategic Plan for Autoimmune Disease Research Read More »

NIH’s New Policy on AI and Proposal Limits: What You Need to Know

Leave a Comment / Life Sciences, NIH / By

NIH just released NOT-OD-25-132: “Supporting Fairness and Originality in NIH Research Applications.” There are two major changes that will shape how you plan and submit proposals beginning September 25, 2025: Originality & AI: NIH reiterates that applications must be the investigators’ original work and flags risks from AI-generated text (e.g., plagiarism, fabricated citations). Institutions should

NIH’s New Policy on AI and Proposal Limits: What You Need to Know Read More »

DOE unveils $1B in critical mineral funding

Leave a Comment / DOE, Emerging Technologies / By

Introduction The U.S. Department of Energy (DOE) has announced nearly $1 billion in funding to strengthen domestic critical minerals supply chains. This initiative targets mining, processing, and manufacturing technologies for essential materials such as rare earths, battery components, and specialty elements. It represents a major opportunity for companies prepared to advance clean energy, semiconductors, and

DOE unveils $1B in critical mineral funding Read More »

Inside the New Executive Order on Strategic API Reserves

Leave a Comment / ASPR-IBx, Life Sciences / By

Introduction On August 13, 2025, President Trump signed a sweeping Executive Order titled “Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve.” The order addresses a long-standing vulnerability in the U.S. healthcare system, the nation’s heavy reliance on foreign suppliers for the active pharmaceutical ingredients (APIs) that make up the

Inside the New Executive Order on Strategic API Reserves Read More »

DTRA’s “Plume” RFI for Marine Toxin Aerosol Exposure Models

Leave a Comment / DTRA, Life Sciences / By

Advancing Countermeasures for Marine Toxin Threats The Defense Threat Reduction Agency (DTRA), through its Research and Development Chemical and Biological Technologies Directorate in support of the Joint Science and Technology Office (JSTO), has issued a Request for Information (RFI) titled “Plume”. This initiative seeks information on the capabilities and availability of suitable animal models for

DTRA’s “Plume” RFI for Marine Toxin Aerosol Exposure Models Read More »

Scroll to Top